FLC Capital Advisors Buys 100 Shares of The Allstate Co. (NYSE:ALL)

FLC Capital Advisors grew its holdings in The Allstate Co. (NYSE:ALL) by 6.2% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,726 shares of the insurance provider’s stock after acquiring an additional 100 shares during the quarter. FLC Capital Advisors’ holdings in Allstate were worth $327,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Rise Advisors LLC bought a new stake in Allstate during the first quarter worth about $26,000. Northwest Investment Counselors LLC acquired a new stake in Allstate during the 1st quarter valued at approximately $26,000. Versant Capital Management Inc increased its position in Allstate by 70.9% during the 2nd quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after purchasing an additional 78 shares during the period. Family Firm Inc. bought a new position in shares of Allstate during the 2nd quarter worth approximately $38,000. Finally, MCF Advisors LLC boosted its holdings in shares of Allstate by 33.9% during the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after buying an additional 84 shares in the last quarter. Institutional investors own 76.47% of the company’s stock.

Insider Transactions at Allstate

In other Allstate news, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares of the company’s stock, valued at $5,236,922.32. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Thomas J. Wilson sold 90,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the transaction, the chief executive officer now directly owns 88,552 shares of the company’s stock, valued at $15,880,915.68. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 192,530 shares of company stock valued at $34,967,665. Insiders own 1.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. Keefe, Bruyette & Woods increased their target price on Allstate from $199.00 to $208.00 and gave the stock an “outperform” rating in a report on Monday, August 12th. Piper Sandler increased their target price on Allstate from $188.00 to $196.00 and gave the stock an “overweight” rating in a report on Friday, August 16th. Evercore ISI raised their price objective on Allstate from $191.00 to $195.00 and gave the company an “in-line” rating in a research note on Wednesday, October 9th. UBS Group raised their price objective on Allstate from $215.00 to $216.00 and gave the company a “buy” rating in a research note on Tuesday. Finally, BMO Capital Markets raised their price objective on Allstate from $191.00 to $205.00 and gave the company an “outperform” rating in a research note on Monday, August 5th. One research analyst has rated the stock with a sell rating, two have given a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Allstate currently has a consensus rating of “Moderate Buy” and a consensus price target of $201.06.

Allstate Stock Performance

NYSE:ALL opened at $195.64 on Thursday. The business has a 50 day moving average of $185.67 and a 200 day moving average of $173.49. The company has a market capitalization of $51.63 billion, a price-to-earnings ratio of 43.19, a PEG ratio of 1.74 and a beta of 0.48. The Allstate Co. has a 1-year low of $121.70 and a 1-year high of $195.87. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.36 and a quick ratio of 0.36.

Allstate (NYSE:ALL) last announced its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $1.61 EPS for the quarter, topping analysts’ consensus estimates of $0.33 by $1.28. Allstate had a return on equity of 24.05% and a net margin of 5.03%. The business had revenue of $15.71 billion for the quarter, compared to analysts’ expectations of $14.04 billion. During the same period in the previous year, the firm earned ($4.42) EPS. The business’s quarterly revenue was up 12.4% on a year-over-year basis. On average, sell-side analysts predict that The Allstate Co. will post 15.19 earnings per share for the current fiscal year.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.